Jack D Burton

Summary

Affiliation: Garden State Cancer Center
Country: USA

Publications

  1. pmc Potential of peroxisome proliferator-activated receptor gamma antagonist compounds as therapeutic agents for a wide range of cancer types
    Jack D Burton
    Coney Island Hospital, 2601 Ocean Parkway, Brooklyn, NY 11235, USA
    PPAR Res 2008:494161. 2008
  2. ncbi request reprint CD74 is expressed by multiple myeloma and is a promising target for therapy
    Jack D Burton
    Center for Molecular Medicine and Immunology and Garden State Cancer Center, Belleville, New Jersey 07109, USA
    Clin Cancer Res 10:6606-11. 2004
  3. ncbi request reprint Peroxisome proliferator-activated receptor-gamma antagonists exhibit potent antiproliferative effects versus many hematopoietic and epithelial cancer cell lines
    Jack D Burton
    Center for Molecular Medicine and Immunology, Belleville, New Jersey 07109, USA
    Anticancer Drugs 18:525-34. 2007
  4. ncbi request reprint New agents and approaches to the treatment of B-cell non-Hodgkin lymphoma
    Jack D Burton
    Hematology Oncology Division, Coney Island Hospital, 2601 Ocean Parkway, Brooklyn, NY 11235, USA
    Expert Opin Emerg Drugs 15:569-83. 2010
  5. ncbi request reprint The MTT assay to evaluate chemosensitivity
    Jack D Burton
    Garden State Cancer Center, Belleville, NJ, USA
    Methods Mol Med 110:69-78. 2005

Research Grants

Detail Information

Publications5

  1. pmc Potential of peroxisome proliferator-activated receptor gamma antagonist compounds as therapeutic agents for a wide range of cancer types
    Jack D Burton
    Coney Island Hospital, 2601 Ocean Parkway, Brooklyn, NY 11235, USA
    PPAR Res 2008:494161. 2008
    ..Since PPARgamma antagonists represent a new drug class that holds promise as a broadly applicable therapeutic approach for cancer treatment, it is the subject of this review...
  2. ncbi request reprint CD74 is expressed by multiple myeloma and is a promising target for therapy
    Jack D Burton
    Center for Molecular Medicine and Immunology and Garden State Cancer Center, Belleville, New Jersey 07109, USA
    Clin Cancer Res 10:6606-11. 2004
    ..Preclinical efficacy of anti-CD74 monoclonal antibody (mAb) therapy has been demonstrated in B-lymphoma models. Because there are few validated antigenic targets in multiple myeloma, CD74 expression was examined...
  3. ncbi request reprint Peroxisome proliferator-activated receptor-gamma antagonists exhibit potent antiproliferative effects versus many hematopoietic and epithelial cancer cell lines
    Jack D Burton
    Center for Molecular Medicine and Immunology, Belleville, New Jersey 07109, USA
    Anticancer Drugs 18:525-34. 2007
    ..These findings support further translational studies to explore the mechanism of action and therapeutic potential of this class of agents...
  4. ncbi request reprint New agents and approaches to the treatment of B-cell non-Hodgkin lymphoma
    Jack D Burton
    Hematology Oncology Division, Coney Island Hospital, 2601 Ocean Parkway, Brooklyn, NY 11235, USA
    Expert Opin Emerg Drugs 15:569-83. 2010
    ..Current treatments are generally effective, but only a minority of this large group of patients can be cured...
  5. ncbi request reprint The MTT assay to evaluate chemosensitivity
    Jack D Burton
    Garden State Cancer Center, Belleville, NJ, USA
    Methods Mol Med 110:69-78. 2005
    ..Newer tetrazolium dyes that yield water-soluble products and offer added flexibility, increases in sensitivity, and fewer steps, which are offset by increased costs, are also covered...

Research Grants2

  1. Chronobiological Principles to Maximize Efficacy of Alt*
    Jack Burton; Fiscal Year: 2004
    ..The results of this work will lend itself to (a) future chronobiological studies of other dietary agents for both therapy and chemoprevention and (b) translation of results into clinical trials. ..
  2. Chronochemoprevention of Prostate Cancer
    Jack Burton; Fiscal Year: 2007
    ....